These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20515556)

  • 1. The potential for serum p53 to predict the response to chemotherapy of patients with gastric cancer.
    Zhang J; He XH; Xie XY; Hu X; He C
    J Int Med Res; 2010; 38(2):423-31. PubMed ID: 20515556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancer.
    Xu HW; Xu L; Hao JH; Qin CY; Liu H
    J Int Med Res; 2010; 38(1):34-42. PubMed ID: 20233511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [p53 and Bax protein expression as predictor of chemotherapeutic effect in gastric carcinoma].
    Muguruma K; Nakata B; Hirakawa K; Yamashita Y; Onoda N; Inoue T; Matsuoka T; Kato Y; Sowa M
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():400-3. PubMed ID: 9589042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer.
    Zheng WE; Chen H; Yuan SF; Wu LL; Zhang W; Sun HY; Chen WJ
    J BUON; 2012; 17(2):284-90. PubMed ID: 22740207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetuximab combined with cisplatin improves the prognosis of gastric cancer patients and its effect on P38 MAPK expression.
    Chen Q; Shen L; Chen C; He H; Fu Y; Xu L; Wang Y
    J BUON; 2019; 24(6):2490-2498. PubMed ID: 31983124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.
    Ock CY; Nam AR; Bang JH; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
    Gastric Cancer; 2017 Jan; 20(1):164-174. PubMed ID: 26681196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].
    Dong NN; Wang MY; Zhang Q; Liu ZF
    Ai Zheng; 2009 Apr; 28(4):412-5. PubMed ID: 19622303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of adjuvant intraperitoneal chemotherapy effect prognosis of resectable gastric cancer.
    Shi C; Yang B; Chen Q; Yang J; Fan N
    Oncology; 2011; 80(5-6):289-95. PubMed ID: 21778768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of preoperative combined chemotherapy with neocarzinostatin (NCS) and 5-Fluorouracil (combined NF therapy) against gastric cancer.
    Okada K; Kitade F; Kawashima Y; Yamada S; Sakuramoto K; Okajima K
    Bull Osaka Med Sch; 1981 Oct; 27(2):65-78. PubMed ID: 6295535
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum level of HER-2/neu in patients with gastric cancer: correlation with HER-2/neu overexpression in gastric carcinoma tissue.
    Kono K; Naganuma H; Sekikawa T; Amemiya H; Takahashi A; Iizuka H; Matsumoto Y
    Tumour Biol; 2000; 21(3):139-44. PubMed ID: 10754464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
    Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
    Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
    Wei Z; Wu Y; Zhai Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study on safety and efficacy of Yadanzi® (Javanica oil emulsion injection) combined with chemotherapy for patients with gastric cancer.
    Liu J; Huang XE; Tian GY; Cao J; Lu YY; Wu XY; Xiang J
    Asian Pac J Cancer Prev; 2013; 14(3):2009-12. PubMed ID: 23679309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.
    Park HS; Jung M; Kim HS; Kim HI; An JY; Cheong JH; Hyung WJ; Noh SH; Kim YI; Chung HC; Rha SY
    Ann Surg Oncol; 2015 Jan; 22(1):224-31. PubMed ID: 25081339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unusually high levels of serum p53 antibody in recurrent gastric cancer.
    Kunizaki M; Hamasaki K; Wakata K; Hidaka S; Nagayasu T; Kinoshita Y
    Clin J Gastroenterol; 2017 Dec; 10(6):503-507. PubMed ID: 28952039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.
    Seo HY; Park JM; Park KH; Kim SJ; Oh SC; Kim BS; Kim YH; Kim JS
    Jpn J Clin Oncol; 2010 Dec; 40(12):1147-53. PubMed ID: 20647232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with irinotecan and cisplatin.
    Nagashima F; Boku N; Ohtsu A; Yoshida S; Hasebe T; Ochiai A; Sakata Y; Saito H; Miyata Y; Hyodo I; Ando M
    Jpn J Clin Oncol; 2005 Dec; 35(12):714-9. PubMed ID: 16303791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous metastases from gastric adenocarcinoma treated with combination chemotherapy producing complete response with long survival.
    Michiwa Y; Earashi M; Kobayashi H; Matsuki N
    J Exp Clin Cancer Res; 2001 Jun; 20(2):297-9. PubMed ID: 11484991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GRP78 expression in gastric cancer and its clinical significance].
    Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.